Chat with us, powered by LiveChat

Past

Nonclinical Carcinogenicity Studies: Fundamentals, Case Studies and Regulatory Trends

Dr. Susanne Stalford, Lhasa Principal Scientist, presented within a Pharmaceutical & BioScience Society workshop, on the topic of Nonclinical Carcinogenicity Studies. The workshop included presentations from regulatory and industry perspectives, on topics relating to carcinogenicity assessment of pharmaceuticals, including: The challenges faced with carcinogenicity assessments, in the development of pharmaceuticals Regulatory and industry perspectives on […]

Nonclinical Carcinogenicity Studies: Fundamentals, Case Studies and Regulatory Trends Read More »

Extractables & Leachables USA

We thoroughly enjoyed attending Extractables and Leachables USA! This event offered a unique opportunity for E&L industry experts to gather and discuss the latest updates on regulations, best practices, compliance, case studies, biocompatibility, and more. Lhasa Application Scientist, Charlie Modlin presented “Using expert knowledge and machine learning to assess the mutagenicity and skin sensitisation potential

Extractables & Leachables USA Read More »

Pharmaceutical Industry and Regulators Symposium

We were delighted to return to Brasilia to host the Pharmaceutical Industry and Regulators Symposium! Held at the the Auditório do Conselho Federal de Farmácia, this two-day event featured insightful presentations from speakers from both industry and regulators. The Symposium brought together like-minded researchers and regulators, offering attendees a unique opportunity to gain a greater

Pharmaceutical Industry and Regulators Symposium Read More »

Society of Toxicology (SOT) 62nd Annual Meeting and ToxExpo

Held in Nashville, Tennessee, the SOT 62nd Annual Meeting and ToxExpo featured an array of scientific sessions, posters and presentations. A team of us from Lhasa attended the event, where we hosted two exhibitor-hosted sessions: Tackling ICH S1B using AOPs Supporting drug development using in silico solutions Lhasa Limited scientific posters, in date order. Poster Title: Mechanisms

Society of Toxicology (SOT) 62nd Annual Meeting and ToxExpo Read More »

7th Impurities: Genotoxic, Nitrosamine & Beyond Summit

We were delighted to attend the 7th Impurities: Genotoxic, Nitrosamine & Beyond summit in Milan, Italy. In addition to focusing on N-nitrosamines, this event explored detecting and reporting genotoxic impurities, as well as recent advances, further development and future considerations towards the different types of impurities present in drugs. Lhasa Principal Scientist, Michael Burns presented

7th Impurities: Genotoxic, Nitrosamine & Beyond Summit Read More »

The 11th International Drug Chemistry Congress

We were excited to attend the 11th International Drug Chemistry Congress! Held at the Antalya-Kemer Mirage Park Resort Hotel from March 9th – 12th, this Congress was helpful for all participants in pharmaceutical R&D and production, as well as the international pharmaceutical industry. Principal Application Scientist, Fernanda Waechter presented on nitrosamines and the Complex Nitrosamines data

The 11th International Drug Chemistry Congress Read More »

Supporting mutagenic impurity and degradant risk assessment using an in silico approach

We recently held our first webinar of 2023, ‘Supporting mutagenic impurity and degradant risk assessment using an in silico approach’. This free-to-attend webinar featured talks from Dr. Andreas Broehl, Laboratory Head at Bayer Pharmaceuticals, and Lhasa Limited Senior Scientist, Dr. Ash Ali. In this exciting virtual event, we explored how our in silico software solution Zeneth, can

Supporting mutagenic impurity and degradant risk assessment using an in silico approach Read More »

United States Pharmacopeia (USP) Workshop on Nitrosamine Impurities

We were excited to attend USP’s Workshop on Nitrosamine Impurities, organised by United States Pharmacopeia (USP) in collaboration with Indian Pharmaceutical Alliance (IPA). Lhasa Principal Scientist, David Ponting presented within the Toxicity Assessment session, his presentation was titled ‘Application of in silico tools (QSAR) to predict toxicity’.  

United States Pharmacopeia (USP) Workshop on Nitrosamine Impurities Read More »